1. Home
  2. CHEK vs DSS Comparison

CHEK vs DSS Comparison

Compare CHEK & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHEK
  • DSS
  • Stock Information
  • Founded
  • CHEK 2004
  • DSS 1984
  • Country
  • CHEK Israel
  • DSS United States
  • Employees
  • CHEK N/A
  • DSS N/A
  • Industry
  • CHEK Medical Electronics
  • DSS Containers/Packaging
  • Sector
  • CHEK Health Care
  • DSS Consumer Discretionary
  • Exchange
  • CHEK Nasdaq
  • DSS Nasdaq
  • Market Cap
  • CHEK 4.8M
  • DSS 8.9M
  • IPO Year
  • CHEK 2015
  • DSS N/A
  • Fundamental
  • Price
  • CHEK $0.79
  • DSS $0.93
  • Analyst Decision
  • CHEK
  • DSS
  • Analyst Count
  • CHEK 0
  • DSS 0
  • Target Price
  • CHEK N/A
  • DSS N/A
  • AVG Volume (30 Days)
  • CHEK 37.4K
  • DSS 189.7K
  • Earning Date
  • CHEK 08-14-2025
  • DSS 08-12-2025
  • Dividend Yield
  • CHEK N/A
  • DSS N/A
  • EPS Growth
  • CHEK N/A
  • DSS N/A
  • EPS
  • CHEK N/A
  • DSS N/A
  • Revenue
  • CHEK N/A
  • DSS $20,180,000.00
  • Revenue This Year
  • CHEK N/A
  • DSS N/A
  • Revenue Next Year
  • CHEK N/A
  • DSS N/A
  • P/E Ratio
  • CHEK N/A
  • DSS N/A
  • Revenue Growth
  • CHEK N/A
  • DSS 12.88
  • 52 Week Low
  • CHEK $0.56
  • DSS $0.72
  • 52 Week High
  • CHEK $3.04
  • DSS $1.63
  • Technical
  • Relative Strength Index (RSI)
  • CHEK 48.85
  • DSS 49.74
  • Support Level
  • CHEK $0.77
  • DSS $0.88
  • Resistance Level
  • CHEK $0.83
  • DSS $0.92
  • Average True Range (ATR)
  • CHEK 0.03
  • DSS 0.07
  • MACD
  • CHEK 0.00
  • DSS -0.00
  • Stochastic Oscillator
  • CHEK 37.05
  • DSS 45.87

About CHEK Check-Cap Ltd.

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

About DSS DSS Inc.

DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia. Product packaging manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the securities trading and/or fund management arena.

Share on Social Networks: